Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
132 hedge funds and large institutions have $548M invested in Albany Molecular Research Inc in 2014 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 33 increasing their positions, 42 reducing their positions, and 21 closing their positions.
1,061% more call options, than puts
Call options by funds: $6.77M | Put options by funds: $583K
90% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 21
17% more funds holding
Funds holding: 113 → 132 (+19)
6% more capital invested
Capital invested by funds: $515M → $548M (+$32.2M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIP
Permian Investment Partners
Dallas,
Texas
|
+$11.4M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.21M |
| 3 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
+$5.05M |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
+$3.56M |
| 5 |
SLCM
Seven Locks Capital Management
New York
|
+$3.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$16.6M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$9.74M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$6.27M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$3.55M |
| 5 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$3.05M |
AMRI Hedge Fund Activity: Q2 2014 in Review
132 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q2 2014, worth a combined $548M — up 6.3% from $515M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new AMRI positions and 21 closed out — a net gain of 19 holders — while 33 added to existing stakes and 42 trimmed.
The largest buyer was Permian Investment Partners, opening a new position worth an estimated $11.4M. The largest seller was Visium Asset Management, cutting an estimated $16.6M.
- 132 institutional investors held Albany Molecular Research Inc (AMRI) as of Q2 2014, up from 113 in Q1 2014.
- Funds reported $548M of Albany Molecular Research Inc stock for Q2 2014, up 6.3% quarter-over-quarter.
- 40 funds opened new Albany Molecular Research Inc positions in Q2 2014 and 21 closed out, a net change of +19 holders.
- The largest Albany Molecular Research Inc buyer in Q2 2014 was Permian Investment Partners, an estimated $11.4M added.
- The largest Albany Molecular Research Inc seller in Q2 2014 was Visium Asset Management, an estimated $16.6M sold.
Based on aggregated 13F filings for Q2 2014.